Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upkar S Gill

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Viral Hepatitis|December 18, 2022
The immune landscape in hepatitis delta virus infection-Still an open fieldUpkar S Gill
Cell Reports. Medicine|February 2, 2022
Making safe sense of an anti-sense!Upkar S Gill, Maud Lemoine
Seminars in Liver Disease|June 1, 2017
Clinical Trial Design for Immune-Based Therapy of Hepatitis B VirusUpkar S Gill, Antonio Bertoletti
Clinical Medicine (London, England)|April 1, 2015
New insights in the management of chronic hepatitis BUpkar S Gill, Patrick Tf Kennedy
Journal of Viral Hepatitis|November 12, 2018
The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeuticsUpkar S Gill, Patrick T F Kennedy
Expert Review of Anti-Infective Therapy|July 24, 2014
Chronic hepatitis B virus in young adults: the need for new approaches to managementUpkar S Gill, Patrick T F Kennedy
Seminars in Liver Disease|October 23, 2024
HBV Biomarkers and Their Role in Guiding Treatment DecisionsLung-Yi Mak, Tobias Boettler, Upkar S Gill
Expert Review of Anti-Infective Therapy|November 19, 2019
Emerging tools in the changing landscape of chronic hepatitis B managementUpkar S Gill, Arianna Battisti, Patrick T F Kennedy
Clinical Medicine (London, England)|November 5, 2025
Chronic hepatitis B in 2025: diagnosis, treatment and future directionsAndrew G Watson, Akhilesh S Mulay, Upkar S Gill
Viruses|May 28, 2022
Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?Apostolos Koffas, Lung-Yi Mak, Upkar S Gill, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Viral Hepatitis|December 18, 2022
The immune landscape in hepatitis delta virus infection-Still an open fieldUpkar S Gill
Cell Reports. Medicine|February 2, 2022
Making safe sense of an anti-sense!Upkar S Gill, Maud Lemoine
Seminars in Liver Disease|June 1, 2017
Clinical Trial Design for Immune-Based Therapy of Hepatitis B VirusUpkar S Gill, Antonio Bertoletti
Clinical Medicine (London, England)|April 1, 2015
New insights in the management of chronic hepatitis BUpkar S Gill, Patrick Tf Kennedy
Journal of Viral Hepatitis|November 12, 2018
The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeuticsUpkar S Gill, Patrick T F Kennedy
Expert Review of Anti-Infective Therapy|July 24, 2014
Chronic hepatitis B virus in young adults: the need for new approaches to managementUpkar S Gill, Patrick T F Kennedy
Seminars in Liver Disease|October 23, 2024
HBV Biomarkers and Their Role in Guiding Treatment DecisionsLung-Yi Mak, Tobias Boettler, Upkar S Gill
Expert Review of Anti-Infective Therapy|November 19, 2019
Emerging tools in the changing landscape of chronic hepatitis B managementUpkar S Gill, Arianna Battisti, Patrick T F Kennedy
Clinical Medicine (London, England)|November 5, 2025
Chronic hepatitis B in 2025: diagnosis, treatment and future directionsAndrew G Watson, Akhilesh S Mulay, Upkar S Gill
Viruses|May 28, 2022
Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?Apostolos Koffas, Lung-Yi Mak, Upkar S Gill, et al.
Pageof 6